[Stem cells in regenerative medicine - from bench to bedside]

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Translational Science

Background:

• Mesenchymal stem cells (MSCs) are increasingly explored for regenerative medicine applications.
• Despite scientific promise, the clinical application of MSC-based therapies remains limited.
• Several challenges impede the progression of MSC therapies from laboratory research to patient use.

Purpose of the Study:

• To identify and analyze the primary obstacles in translating stem cell-based therapies.
• To highlight the key issues hindering the clinical adoption of mesenchymal stem cell treatments.
• To provide insights into the translational gap in stem cell research.

Main Methods:

• Review of current literature on mesenchymal stem cell therapy translation.
• Analysis of ethical, legal, and safety considerations impacting clinical use.
• Identification of barriers in the progression from basic science to clinical application.

Main Results:

• Significant ethical and translational questions pose challenges.
• Legal aspects and safety uncertainties impede therapy development.
• The path from basic research to clinical use for MSC therapies is complex.

Conclusions:

• Addressing ethical, legal, and safety concerns is crucial for advancing MSC therapies.
• Overcoming translational hurdles is essential for realizing the potential of stem cell-based regenerative medicine.
• Further research and regulatory clarity are needed to facilitate clinical implementation.